CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...